¼¼°èÀÇ Á¤Çü¿Ü°ú¿ë ½ºÇÁ¸°Æ® ½ÃÀå ±Ô¸ð : Á¦Ç°º°, ¿ëµµº°, ÃÖÁ¾ ¿ëµµº°, ¿¹Ãø(2023-2032³â)
Orthopedic Splints Market Size - By Product (Fiberglass Splints, Plaster Splints, Tools & Accessories), By Application (Upper Extremity, Lower Extremity), By End-use, & Forecast, 2023 - 2032
»óǰÄÚµå
:
1351535
¸®¼Ä¡»ç
:
Global Market Insights Inc.
¹ßÇàÀÏ
:
2023³â 07¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹® 180 Pages
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
Á¤Çü¿Ü°ú¿ë ½ºÇÁ¸°Æ®(Orthopedic Splints) ½ÃÀå ±Ô¸ð´Â ½ºÆ÷Ã÷ ¹× ·¹Å©¸®¿¡ÀÌ¼Ç È°µ¿ Âü¿© Áõ°¡¿¡ °ßÀεǾî 2023³âºÎÅÍ 2032³â±îÁö CAGR 8.3%·Î ÃßÀÌÇÏ¸ç ¼ºÀå ÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
½ºÆ÷Ã÷ ¹× ü·Â ´Ü·Ã¿¡ ´ëÇÑ Âü¿©°¡ Áõ°¡ÇÔ¿¡ µû¶ó ¿°ÁÂ, °ñÀý, ÀÎ´ë ÆÄ¿°ú °°Àº Á¤Çü¿Ü°úÀû ºÎ»óÀÇ À§ÇèÀÌ Å©°Ô Áõ°¡Çß½À´Ï´Ù. 2022³â¿¡´Â 360¸¸ ¸íÀÇ »ç¶÷µéÀÌ ½ºÆ÷Ã÷ ¹× ·¹Àú Àåºñ·Î ÀÎÇÑ ºÎ»óÀ¸·Î ÀÀ±Þ½Ç¿¡¼ Ä¡·á¸¦ ¹Þ¾Ò½À´Ï´Ù. µû¶ó¼ ½ºÆ÷Ã÷ °ü·Ã ºÎ»óÀÇ °ü¸® ¹× ȸº¹¿¡ ÀÖ¾î Á¤Çü¿Ü°ú¿ë ½ºÇÁ¸°Æ®ÀÇ Á߿伺ÀÌ ³ô¾ÆÁü¿¡ µû¶ó ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ½ºÇÁ¸°Æ® µðÀÚÀΰú ¼ÒÀçÀÇ ¹ßÀüÀ¸·Î Æí¾ÈÇϰí È¿°úÀûÀÎ ºÎ¸ñÀÌ °³¹ßµÇ¾î ½ºÆ÷Ã÷ ¹× ·¹Å©¸®¿¡ÀÌ¼Ç ºÎ¹®¿¡¼ ½ºÇÁ¸°Æ®ÀÇ Ã¤ÅÃÀÌ ´õ¿í ÃËÁøµÇ°í ÀÖ½À´Ï´Ù.
Á¦Ç°º°·Î´Â Åø ¾×¼¼¼¸® ºÎ¹®ÀÇ Á¤Çü¿Ü°ú¿ë ½ºÇÁ¸°Æ® ½ÃÀåÀÌ 2032³â±îÁö CAGR 7.8%¸¦ ±â·ÏÇÒ Àü¸ÁÀÔ´Ï´Ù. Á¤Çü¿Ü°ú Àü¹®°¡´Â ȯÀÚ¸¦ À§ÇÑ ½ºÇÁ¸°Æ®¸¦ È¿°úÀûÀ¸·Î ¸¸µé°í ¸ÂÃãÈÇϱâ À§ÇØ °íǰÁú µµ±¸ ¾×¼¼¼¸®¿¡ Å©°Ô ÀÇÁ¸ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ µµ±¸ÀÇ Çõ½ÅÀº Á¤È®¼º°ú È¿À²¼º Çâ»óÀ¸·Î À̾îÁ³À¸¸ç, ÀÇ·á ¼ºñ½º Á¦°ø¾÷ü´Â ´õ¿í ¸ÂÃãÈµÇ°í Æí¾ÈÇÑ ½ºÇÁ¸°Æ® ¼Ö·ç¼ÇÀ» Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù.
ÃÖÁ¾ ¿ëµµ¿¡ µû¶ó Á¤Çü¿Ü°ú¿ë ½ºÇÁ¸°Æ® ½ÃÀåÀº 2032³â±îÁö Àü¹®¼¾ÅÍ ºÎ¹®¿¡¼ 8.8%ÀÇ CAGR·Î ÃßÀÌÇϸç È®´ëµÉ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. Á¤Çü¿Ü°ú Ŭ¸®´Ð°ú ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)¿Í °°Àº Àü¹®¼¾Åʹ ȯÀÚ¿¡°Ô Àü¹®ÀûÀÎ Á¤Çü¿Ü°ú Ä¡·á ¹× Àü¹® Ä¡·á ¹× Ä¡·á¿¡ Æí¸®ÇÑ ¾×¼¼½º¸¦ Á¦°øÇϱâ À§ÇØ °Ç° °ü¸® »ê¾÷¿¡¼ Á¡Á¡ ´õ Á¸Àç°¨À» ¾ò°í ÀÖ½À´Ï´Ù.
¶ÇÇÑ, ÇコÄÉ¾î ±â¾÷Àº ¼ºñ½º Æ÷Æ®Æú¸®¿À¸¦ È®´ëÇÏ°í µµ´Þ¹üÀ§¸¦ ³ÐÈ÷±â À§ÇÑ ÅõÀÚ¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù.
Áö¿ªº°·Î´Â À¯·´ÀÇ Á¤Çü¿Ü°ú¿ë ½ºÇÁ¸°Æ® ½ÃÀåÀº ±Þ¼ÓÇÑ °í·ÉÈ¿¡ °ßÀεǾî 2023-2032³âÀÇ CAGRÀÌ 8.1%°¡ µÉ °ÍÀ¸·Î ¿¹»óµÇ°í ÀÖ½À´Ï´Ù. ÀÌ Áö¿ª¿¡¼´Â ³ëÀÎ Àα¸ÀÇ °ñ´Ù°øÁõÀÇ °á°ú·Î Ãë¾à¼º °ñÀýÀÌ ¸¸¿¬Çϰí ÀÖ½À´Ï´Ù. 2022³â¿¡ ¹ßÇ¥µÈ EFORT ±â±¸ÀÇ Á¶»ç¿¡ ÀÇÇϸé, °ñ´Ù°øÁõÀº À¯·´ ÁÖ¿ä 5°³±¹ÀÇ 50-94¼¼ ¿©¼ºÀÇ 21%, ³²¼ºÀÇ 6%°¡ ÀÌȯÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ °í±Þ ÀÇ·á ÀÎÇÁ¶ó¿Í ȯÀÚ Á᫐ °ü¸®¿¡ ÁßÁ¡À» µÎ¸é Çõ½ÅÀûÀÎ ½ºÇÁ¸°Æ® ±â¼ú°ú Àç·á äÅÃÀ» ÃËÁøÇϰí Áö¿ª ½ÃÀå ¼ºÀå¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù.
¸ñÂ÷
Á¦1Àå Á¶»ç ¹æ¹ý ¹× ¹üÀ§
Á¦2Àå ÁÖ¿ä ¿ä¾à
Á¦3Àå Á¤Çü¿Ü°ú¿ë ½ºÇÁ¸°Æ® »ê¾÷ ÀλçÀÌÆ®
- »ýÅÂ°è ºÐ¼®
- »ê¾÷¿¡ ¹ÌÄ¡´Â ¿µÇâ ¿äÀÎ
- ¼ºÀå ÃËÁø ¿äÀÎ
- Á¤Çü¿Ü°ú ÁúȯÀÇ À¯º´·ü Áõ°¡
- Á¤Çü¿Ü°ú¿ë ½ºÇÁ¸°Æ®ÀÇ ±â¼úÀû Áøº¸
- °í·ÉÈ »çȸ¿¡¼ ¿Ü»ó Áõ°¡
- Àúħ½À ¼ö¼ú¿¡ ´ëÇÑ ¼±È£µµ Áõ°¡
- »ê¾÷ÀÇ ÀáÀçÀû À§Çè ¹× °úÁ¦
- Á¤Çü¿Ü°ú¿ë ½ºÇÁ¸°Æ®ÀÇ °íºñ¿ë
- ´ëü Ä¡·á ¿É¼ÇÀÇ °¡¿ë¼º
- ¼ºÀå °¡´É¼º ºÐ¼®
- Á¦Ç°º°
- ¿ëµµº°
- ÃÖÁ¾ ¿ëµµº°
- COVID-19ÀÇ ¿µÇ⠺м®
- ±ÔÁ¦ »óȲ
- ÁÖ¿ä ½ÃÀå µ¿Çâ
- »óȯ ½Ã³ª¸®¿À
- ±â¼ú Àü¸Á
- ÇâÈÄ ½ÃÀå µ¿Çâ
- ¹ë·ùüÀÎ ºÐ¼®
- °¸ ºÐ¼®
- Porter's Five Forces ºÐ¼®
- PESTEL ºÐ¼®
Á¦4Àå °æÀï ±¸µµ
- ¼Ò°³
- ±â¾÷ ¸ÅÆ®¸¯½º ºÐ¼®
- ¼¼°è ±â¾÷ Á¡À¯À² ºÐ¼®
- º¥´õ ¸ÅÆ®¸¯½º ºÐ¼®
- °æÀï Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º
- Àü·« ´ë½Ãº¸µå
Á¦5Àå Á¤Çü¿Ü°ú¿ë ½ºÇÁ¸°Æ® ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø : Á¦Ç°º°
- ÁÖ¿ä µ¿Çâ : Á¦Ç°º°
- À¯¸® ¼¶À¯ ½ºÇÁ¸°Æ®
- ¼®°í ½ºÇÁ¸°Æ®
- Åø¡¤¾×¼¼¼¸®
- ±âŸ
Á¦6Àå Á¤Çü¿Ü°ú¿ë ½ºÇÁ¸°Æ® ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø : ¿ëµµº°
- ÁÖ¿ä µ¿Çâ : ¿ëµµº°
- »óÁö
- ¾î±ú °üÀý
- ÆÈ²ÞÄ¡ °üÀý
- ¼Õ¡¤¼Õ¸ñ
- ÇÏÁö
- °í°üÀý
- ¹«¸ °üÀý
- ¹ß¸ñ¡¤¹ß
Á¦7Àå Á¤Çü¿Ü°ú¿ë ½ºÇÁ¸°Æ® ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø : ÃÖÁ¾ ¿ëµµº°
- ÁÖ¿ä µ¿Çâ : ÃÖÁ¾ ¿ëµµº°
- º´¿ø
- Àü¹®¼¾ÅÍ
- ±âŸ
Á¦8Àå Á¤Çü¿Ü°ú¿ë ½ºÇÁ¸°Æ® ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø : Áö¿ªº°
- ÁÖ¿ä µ¿Çâ :Áö¿ªº°
- ºÏ¹Ì
- À¯·´
- µ¶ÀÏ
- ¿µ±¹
- ÇÁ¶û½º
- ½ºÆäÀÎ
- ÀÌÅ»¸®¾Æ
- ½º¿þµ§
- Æú¶õµå
- ³×´ú¶õµå
- ¾Æ½Ã¾Æ ÅÂÆò¾ç
- Áß±¹
- ÀϺ»
- Àεµ
- È£ÁÖ
- Çѱ¹
- Àεµ³×½Ã¾Æ
- ű¹
- Çʸ®ÇÉ
- ³²¹Ì
- ºê¶óÁú
- ¸ß½ÃÄÚ
- ¾Æ¸£ÇîÆ¼³ª
- ÄÝ·Òºñ¾Æ
- Ä¥·¹
- Æä·ç
- MEA
- ³²¾ÆÇÁ¸®Ä«°øÈ±¹
- »ç¿ìµð¾Æ¶óºñ¾Æ
- ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
- À̽º¶ó¿¤
- ÀÌÁýÆ®
- ÅÍŰ
Á¦9Àå ±â¾÷ °³¿ä
- 3M
- Becton, Dickinson and Company
- Breg, Inc.
- DeRoyal Industries, Inc.
- DJO Global
- Dynatronics Corporation
- Essity AB
- Medi GmbH & Co. KG
- Orthosys
- Ossur
- Ottobock
- Sam Medical
- Stryker Corporation
- United Medicare
- Zimmer Biomet
LYJ
¿µ¹® ¸ñÂ÷
Orthopedic Splints Market size is anticipated to record 8.3% CAGR from 2023-2032 driven by the increasing participation in sports and recreational activities.
With the rising engagement in sports and physical fitness pursuits, the risk of orthopedic injuries, such as sprains, fractures, and ligament tears has significantly soared. In 2022, 3.6 million individuals were treated in emergency rooms for injuries caused by sports and leisure equipment. The robust demand for orthopedic splints is thus growing due to their higher importance in the management and recovery of sports-related injuries. Moreover, advancements in splint design and materials have made way for comfortable and effective splints, further fueling their adoption in the sports and recreation sector.
The orthopedic splints market is segmented based on product, application, end-use, and region.
In terms of product, the orthopedic splints market from the tools & accessories segment is expected to strike 7.8% CAGR through 2032. Orthopedic professionals heavily rely on high-quality tools and accessories to create and customize splints for patients effectively. Innovations in these tools have led to improved precision and efficiency, allowing healthcare providers to offer more tailored and comfortable splinting solutions.
Based on end-use, the orthopedic splints market from the specialty centers segment is estimated to expand at 8.8% growth rate through 2032. Specialty centers, including orthopedic clinics and ambulatory surgical centers, are becoming increasingly prominent in the healthcare landscape to provide specialized orthopedic care and convenient access to expert treatments and procedures to patients.
Moreover, healthcare companies are focusing on investments to expand their service portfolio and broaden their reach. For instance, in November 2022, MedCraft Investment Partners acquired the facility housing South Bend Orthopedics' medical offices and Allied Physicians Surgery Center to continue providing patients with cutting-edge care in affordable outpatient environment.
Regionally, the Europe orthopedic splints market is expected to witness 8.1% CAGR during 2023-2032, driven by the rapidly aging population. Fragility fractures are becoming more prevalent in the region as a result of osteoporosis among the older population. According to EFORT Organization research published in 2022, osteoporosis affects 21% of women and 6% of men between the ages of 50 and 94 in five major European nations. Moreover, the advanced healthcare infrastructure and focus on patient-centered care are driving the adoption of innovative splinting technologies and materials, adding to the regional market growth.
Table of Contents
Chapter 1 Methodology & Scope
- 1.1 Industry coverage
- 1.2 Market scope & definition
- 1.3 Base estimates & calculations
- 1.4 Forecast parameters
- 1.5 COVID-19 impact analysis at global level
- 1.6 Data validation
- 1.7 Data Sources
- 1.7.1 Primary
- 1.7.2 Secondary
- 1.7.2.1 Paid sources
- 1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
- 2.1 Orthopedic splints industry 360 degree synopsis, 2018 - 2032
- 2.2 Business trends
- 2.3 Regional trends
- 2.4 Product trends
- 2.5 Application trends
- 2.6 End-use trends
Chapter 3 Orthopedic Splints Industry Insights
- 3.1 Industry ecosystem analysis
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Increasing prevalence of orthopedic diseases
- 3.2.1.2 Technological advancements in orthopedic splints
- 3.2.1.3 Rising incidence of trauma and injuries among ageing population
- 3.2.1.4 Increasing preference for minimally invasive surgeries
- 3.2.2 Industry pitfalls & challenges
- 3.2.2.1 High cost of orthopedic splints
- 3.2.2.2 Availability of alternative treatment options
- 3.3 Growth potential analysis
- 3.3.1 By product
- 3.3.2 By application
- 3.3.3 By end-use
- 3.4 COVID- 19 impact analysis
- 3.5 Regulatory landscape
- 3.6 Key market trends
- 3.7 Reimbursement scenario
- 3.8 Technology landscape
- 3.9 Future market trends
- 3.10 Value chain analysis
- 3.11 Gap Analysis
- 3.12 Porter's analysis
- 3.13 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
- 4.1 Introduction
- 4.2 Company matrix analysis, 2022
- 4.3 Global company market share analysis, 2022
- 4.4 Vendor matrix analysis
- 4.5 Competitive positioning matrix
- 4.6 Strategy dashboard, 2022
Chapter 5 Orthopedic Splints Market Size and Forecast, By Product (USD Million & Units)
- 5.1 Key trends, by product
- 5.2 Fiberglass splints
- 5.3 Plaster splints
- 5.4 Tools & accessories
- 5.5 Others
Chapter 6 Orthopedic Splints Market Size and Forecast, By Application (USD Million)
- 6.1 Key trends, by application
- 6.2 Upper extremity
- 6.2.1 Shoulder
- 6.2.2 Elbow
- 6.2.3 Hand and wrist
- 6.3 Lower extremity
- 6.3.1 Hip
- 6.3.2 Knee
- 6.3.3 Ankle & foot
Chapter 7 Orthopedic Splints Market Size and Forecast, By End-use (USD Million)
- 7.1 Key trends, by end-use
- 7.2 Hospitals
- 7.3 Specialty Centers
- 7.4 Others
Chapter 8 Orthopedic Splints Market Size and Forecast, By Region (USD Million & Units)
- 8.1 Key trends, by region
- 8.2 North America
- 8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Sweden
- 8.3.7 Poland
- 8.3.8 The Netherlands
- 8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Indonesia
- 8.4.7 Thailand
- 8.4.8 Philippines
- 8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Colombia
- 8.5.5 Chile
- 8.5.6 Peru
- 8.6 MEA
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Israel
- 8.6.5 Egypt
- 8.6.6 Turkey
Chapter 9 Company Profiles
- 9.1 3M
- 9.2 Becton, Dickinson and Company
- 9.3 Breg, Inc.
- 9.4 DeRoyal Industries, Inc.
- 9.5 DJO Global
- 9.6 Dynatronics Corporation
- 9.7 Essity AB
- 9.8 Medi GmbH & Co. KG
- 9.9 Orthosys
- 9.10 Ossur
- 9.11 Ottobock
- 9.12 Sam Medical
- 9.13 Stryker Corporation
- 9.14 United Medicare
- 9.15 Zimmer Biomet
°ü·ÃÀÚ·á